| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.2 |